Quiksilver (ZQK) 0.45 $ZQK Quiksilver Receives Court

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Quiksilver (ZQK) 0.45 $ZQK

Quiksilver Receives Court Approval for $175 Million DIP Financing
BusinessWire - Thu Sep 10, 6:48PM CDT
--Operations in the U.S. and abroad to continue in ordinary course
ZQK: 0.45 (unch)

Downgrade Alert for Quiksilver (ZQK)
Comtex SmarTrend(R) - Thu Sep 10, 7:21AM CDT
Quiksilver (NYSE:ZQK) was downgraded from Buy to Neutral at B. Riley today. The stock closed yesterday at $0.46 on volume of 0 shares, below average daily volume of 1.3 million. Quiksilver, Inc. designs, produces, and distributes branded apparel, winter sports and golf equipment, footwear, accessories, and related products.
ZQK: 0.45 (unch)

Quiksilver Postpones Filing of Third Quarter 2015 Form 10-Q and Cancels Scheduled Conference Call
BusinessWire - Wed Sep 09, 8:00AM CDT
Quiksilver, Inc. (NYSE:ZQK; the "Company" today announced it has filed a Notification of Late Filing on Form 12b-25 with the Securities and Exchange Commission that the financial statements to be included in the Company's Form 10-Q for the quarter ended July 31, 2015 could not be completed within the required deadline. The Company expects to file such 10-Q no later than September 14, 2015. The Company also announced that it cancelled its previously scheduled conference call to discuss third quarter financial results.
ZQK: 0.45 (unch)

Bummer ... Quiksilver files for Chapter 11 bankruptcy in US
AP - Wed Sep 09, 7:50AM CDT
NEW YORK (AP) — Quiksilver, a ubiquitous clothing brand at surfing hot spots from the U.S. to Australia, filed for Chapter 11 bankruptcy protection for its U.S. division.
ZQK: 0.45 (unch)

Quiksilver US commences voluntary chapter 11 proceedings for its subsidiaries supported by US secured note holders
M2 - Wed Sep 09, 6:20AM CDT
Quiksilver Inc (NYSE:ZQK), an outdoor sports lifestyle company that designs, produces and distributes branded apparel, footwear and accessories, revealed on Wednesday that it commenced voluntary chapter 11 proceedings for its US subsidiaries, for relief under the US Bankruptcy Code in the US Bankruptcy Court for the District of Delaware.
ZQK: 0.45 (unch)

3 Stocks That Could Make Huge Moves This Week
Brian Stoffel, The Motley Fool - Motley Fool - Mon Sep 07, 9:56AM CDT
If you don't prepare yourself, this week might feel just like this. Greetings, Fools. As with every other week, I'm here to give you the names of three stocks that are primed to make big moves this week on Wall Street. Earlier this month, I ...
CONN: 6.84 (+0.18), ZQK: 0.45 (unch), LULU: 76.67 (-0.28)

Quiksilver, Inc. Announces Reporting Date for Third Quarter Fiscal Year 2015 Financial Results
BusinessWire - Fri Aug 21, 7:30AM CDT
Quiksilver, Inc. (NYSE:ZQK) today announced that it plans to issue a press release reporting its fiscal 2015 third quarter financial results after the market closes on Wednesday, September 9, 2015, and will conduct a conference call the same day at 4:30 p.m. Eastern Time to review its results.
ZQK: 0.45 (unch)

Quiksilver Receives Continued Listing Standard Notice from NYSE
BusinessWire - Thu Jul 16, 3:01PM CDT
Quiksilver, Inc. (NYSE:ZQK; the "Company" today announced that on July 10, 2015, the Company was notified by the New York Stock Exchange ("NYSE" that the Company's common stock is not in compliance with the NYSE's continued listing standard that requires a minimum average closing price of $1.00 per share over a period of 30 consecutive trading days.
ZQK: 0.45 (unch)

Several Companies Impacted by S&P Index Changes - Analyst Blog
Swarup Gupta - Zacks Investment Research - Wed Jun 24, 10:19AM CDT
A number of changes were announced across the three major S&P indexes yesterday.
ATI: 17.37 (+0.34), ZQK: 0.45 (unch), FXCM: 9.19 (+0.07), MAS: 36.37 (+0.03), ENR: 49.02 (-1.92), ARO: 0.15 (-0.06), SMTC: 24.24 (-0.04), UNT: 12.34 (+0.74), BTU: 2.07 (unch), NI: 25.50 (-0.44), GCI: 12.05 (-0.01), DD: 68.86 (+0.13), BLD: 37.91 (+0.22), CASY: 130.57 (-1.35), PGN: 0.15 (-0.02), VZ: 53.85 (-0.15)

Columbia Pipeline to Join the S&P 500; Other Changes to S&P MidCap 400 & S&P SmallCap 600
PR Newswire - Wed Jun 24, 6:28AM CDT
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
ATI: 17.37 (+0.34), ZQK: 0.45 (unch), FXCM: 9.19 (+0.07), MHFI: 107.92 (+1.16), ENR: 49.02 (-1.92), GHC: 495.68 (-2.53), MAS: 36.37 (+0.03), NKTR: 17.51 (+0.33), ARO: 0.15 (-0.06), SMTC: 24.24 (-0.04), HSC: 9.64 (+0.24), BTU: 2.07 (unch), UNT: 12.34 (+0.74), NI: 25.50 (-0.44), PQ: 2.41 (+0.04), GCI: 12.05 (-0.01), AOL: 49.99 (+0.03), DD: 68.86 (+0.13), PGN: 0.15 (-0.02), CASY: 130.57 (-1.35), VZ: 53.85 (-0.15)

Stock to Watch: Quiksilver Down 10.8% (ZQK)
Comtex SmarTrend(R) - Mon Jun 15, 10:15AM CDT
Quiksilver (NYSE:ZQK) is one of today's worst performing penny stocks, down 10.8% to $0.57 on 1.0x average daily volume. Thus far today, Quiksilver has traded 2.3 million shares, vs. average volume of 2.3 million shares per day. The stock has underperformed the Dow (-10.8% to the Dow's -0.9%) and underperformed the S&P 500 (-10.8% to the S&P's -0.8%) during today's trading.
ZQK: 0.45 (unch)

What Falling Estimates & Price Mean for Quiksilver Inc. (ZQK) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 15, 7:37AM CDT
Quiksilver Inc. (ZQK) has witnessed a significant price decline and it has seen negative earnings estimate revisions, so it could be time to get rid of the security before more losses hit your portfolio.
ZQK: 0.45 (unch)

Investors look to Lighten Up on Shares of Quiksilver, Shares Down 5.6% (ZQK)
Comtex SmarTrend(R) - Thu Jun 11, 12:49PM CDT
Quiksilver (NYSE:ZQK) is one of today's worst performing penny stocks, down 5.6% to $0.71 on 3.5x average daily volume. Quiksilver has traded 4.6 million shares thus far today, vs. average volume of 1.3 million shares per day. The stock has underperformed the Dow (-5.6% to the Dow's 0.3%) and underperformed the S&P 500 (-5.6% to the S&P's 0.3%) during today's trading.
ZQK: 0.45 (unch)

Oxford Industries and HCC are big market movers
AP - Wed Jun 10, 3:27PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
SIGM: 6.74 (+0.14), GE: 31.11 (+0.06), ZQK: 0.45 (unch), OXM: 56.42 (+0.14), HPQ: 14.21 (+0.15), HOV: 1.72 (+0.05), LULU: 76.67 (-0.28), AAL: 33.35 (-0.16), BDBD: 11.03 (+0.04), RCON: 1.23 (-0.05), HRB: 23.38 (unch), HCC: 77.93 (-0.06), JCI: 45.04 (-0.19)

Company News for June 10, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Jun 10, 9:10AM CDT
Companies in the News are: BURL,LULU,ZQK,HOV
ZQK: 0.45 (unch), BURL: 74.61 (+0.70), HOV: 1.72 (+0.05), LULU: 76.67 (-0.28)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading